İpek Göksun, Tanaçan Atakan, Görmüşer Nazan, Ağaoğlu Zahid, Peker Ayça, Kara Özgür, Şahin Dilek
Turkish Ministry of Health, Ankara City Hospital, Department of Obstetrics and Gynecology, Division of Perinatology - Ankara, Turkey.
Cihanbeyli State Hospital, Department of Obstetrics and Gynecology - Konya, Turkey.
Rev Assoc Med Bras (1992). 2025 May 2;71(3):e20241231. doi: 10.1590/1806-9282.20241231. eCollection 2025.
The aim of this study was to evaluate the role of systemic inflammation response index, systemic immune-inflammation index, platelet/hemoglobin ratio, and other defined low-grade inflammatory indices in predicting preeclampsia.
The presented retrospective case-control study was conducted on 304 patients diagnosed with preeclampsia and 240 low-risk pregnant women who gave birth between 2019 and 2021 in Ankara Bilkent City Hospital, a tertiary center. Patient information was obtained from the hospital database. Patients diagnosed with preeclampsia, along with possible predictive indices in the first trimester, were evaluated to predict the development of preeclampsia. The indices were neutrophil/lymphocyte ratio, AST/platelet ratio, platelet/lymphocyte ratio, lymphocyte/monocyte ratio, platelet/hemoglobin ratio, creatinine/platelet ratio, systemic immune-inflammation index (neutrophil×platelet/lymphocyte), and systemic inflammation response index (neutrophil×monocyte/lymphocyte). These indices were calculated from the first-trimester routine blood test results and compared between preeclampsia and control groups. The indices were also evaluated for the predictive value regarding the severity and onset time of the disease.
In the first trimester, hemoglobin counts were lower in the preeclampsia group, whereas creatinine and monocyte counts were higher. The platelet/hemoglobin count ratio was significantly higher in the preeclampsia group, with a p-value of 0.025. According to receiver operating characteristic analyses, a platelet/hemoglobin count ratio of 21.41 was identified as the optimal cut-off value for the disease prediction.
Systemic inflammation response index and platelet/hemoglobin ratio were evaluated along with the other indices to predict preeclampsia. The platelet/hemoglobin ratio was found to be higher in the preeclampsia group in the first trimester, making it a promising index for preeclampsia prediction.
本研究旨在评估全身炎症反应指数、全身免疫炎症指数、血小板/血红蛋白比值及其他特定的低度炎症指标在预测子痫前期中的作用。
本回顾性病例对照研究在安卡拉比尔肯特市医院(一家三级中心)对2019年至2021年间诊断为子痫前期的304例患者和240例低风险孕妇进行。患者信息从医院数据库中获取。对诊断为子痫前期的患者以及孕早期可能的预测指标进行评估,以预测子痫前期的发生。这些指标包括中性粒细胞/淋巴细胞比值、谷草转氨酶/血小板比值、血小板/淋巴细胞比值、淋巴细胞/单核细胞比值、血小板/血红蛋白比值、肌酐/血小板比值、全身免疫炎症指数(中性粒细胞×血小板/淋巴细胞)和全身炎症反应指数(中性粒细胞×单核细胞/淋巴细胞)。这些指标根据孕早期常规血液检测结果计算得出,并在子痫前期组和对照组之间进行比较。还评估了这些指标对疾病严重程度和发病时间的预测价值。
孕早期,子痫前期组的血红蛋白计数较低,而肌酐和单核细胞计数较高。子痫前期组的血小板/血红蛋白计数比值显著更高,p值为0.025。根据受试者工作特征分析,血小板/血红蛋白计数比值为21.41被确定为疾病预测的最佳截断值。
评估了全身炎症反应指数和血小板/血红蛋白比值以及其他指标以预测子痫前期。发现子痫前期组在孕早期的血小板/血红蛋白比值较高,使其成为子痫前期预测的一个有前景的指标。